C9H14N2O8P2
340.16 g/mol
APIDanger
Minodronic acid monohydrate
CAS155648-60-5
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Minodronic acid monohydrate is a hydrate form of a bisphosphonate compound. It is used as an active pharmaceutical ingredient in pharmaceutical manufacturing.
active pharmaceutical ingredient
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 155648-60-5
Related Compounds
ReferenceSame Category
Pizotyline
CAS15574-96-6
pharmaceutical raw material
ReferenceSame Category
Ivabradine
CAS155974-00-8
pharmaceutical raw material
ReferenceSame Category
Sodium butyrate
CAS156-54-7
pharmaceutical raw material
ReferenceSame Category
Cysteamine hydrochloride
CAS156-57-0
pharmaceutical raw material
Safety Reference
Danger
H301Toxic if swallowed
H361Suspected of damaging fertility or the unborn child
Identifiers
IUPAC Name
(1-hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl)phosphonic acid;hydrate
InChIKey
GPAPAOGRNKUFGH-UHFFFAOYSA-N
SMILES
C1=CC2=NC=C(N2C=C1)CC(O)(P(=O)(O)O)P(=O)(O)O.O
Synonyms (16)
- Bonoteo
- Bonoteo (TN)
- Minodronate Monohydrate
- Minodronate hydrate
- Minodronic acid hydrate (JAN)
- Minodronic acid monohydrate
- Recalbon
- Recalbon (TN)
- YM-529 (hydrate)
- minodronic acid hydrate